Healthcare

- Commitments demonstrate leadership in advancing health equity and workforce representation to better serve patients and communities - $10 million in 2023 grant funding to 17 U.S. organizations focused on addressing social determinants...

Recognition honors companies demonstrating business integrity through best-in-class ethics, compliance, and governance practices DUBLIN -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has been recognized by Ethisphere,...

Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfizer’s position as a leading company in...

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today announced that Gustavo Pesquin will become the company’s next Chief Executive Officer (CEO) as of...

NEW BRUNSWICK, N.J. –Johnson & Johnson (NYSE: JNJ) today announced that Kenvue Inc. (“Kenvue”), a wholly owned subsidiary of Johnson & Johnson, priced an offering of the following series of senior...

Dr. Walker, could you please tell us more about the mission/background of Orlando Health Network? How patients, hospitals, physicians and other stakeholders benefit from this network? Dr. Erik Walker: The...

VitalDose® EVA drug delivery platform to be used in the development of Alessa Therapeutics’ proprietary localized drug delivery technology. DALLAS -- Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, and...

Multi-year agreement will address cardiometabolic conditions and maternal health in under-resourced and underserved communities BENTONVILLE, Ark. —Walmart and CareSource, a nonprofit, nationally recognized managed care organization, announced today it has entered...

AstraZeneca announced today the successful completion of the acquisition of CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as...

-  Partnership Combines AbbVie's extensive capabilities with Capsida's novel adeno-associated virus (AAV) engineering platform -  Builds upon the neurodegenerative disease partnership announced in 2021 NORTH CHICAGO, Ill. and THOUSAND OAKS, Calif. -- AbbVie (NYSE:...